evolocumabezetimibeevolucumabalirocumabrosuvastatinatorvastatinsecondary cardiovascular events or strokes
…ilisin/kexin type 9 inhibitors (PCSK9i), such as alirocumab and evolocumab, effectively manage cLDL levels. However, the relative efficacy…
30articles mentioning drugs
64drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Ezetimibe ×
Ezetimibe
This drug is selected. Its supporting articles are shown below.
Articles mentioning Ezetimibe
30 articles · page 1 of 3bempedoic acidEzetimibenon-fatal myocardial infarctionnon-fatal strokeStatin intolerancepost-myocardial infarctioncardiovascular diseasehospital pharmacy
….31 discounted QALYs at a lifetime cost of 166,513 units, while bempedoic acid yielded 11.01 discounted QALYs at 389,310 units. Compared with …
inclisiranalirocumabezetimibeevolocumabfenofibratestatinbempedoic acidischaemic heart diseaseprimary hypercholesterolaemia
…isease, and three with familial hypercholesterolaemia. Prior to inclisiran, 11 patients (28.9%) had been treated with evolocumab and 2 pat…
AtorvastatinEzetimibeRosuvastatinbempedoic acidPravastatinSimvastatinFibrateCKDHypertensioncardiovascular events
…arget (111) Off target (197) Both groups (308) Statin% 95 85 89 Atorvastatin Total Number% 62 61 62 Mean Dose (mg) 57.71 (SD 25.03) 58.33 (S…
bempedoic acidEzetimibePCSK9 inhibitorsAtorvastatinacute myocardial infarctionatherosclerosisDyslipidaemiahigh-intensity statin therapyST-elevation myocardial infarction
… bempedoic acid, and 2% received a combination of Ezetimibe and bempedoic acid. No patients were initiated on PCSK9 inhibitors.Abstract 7-007 …
Inclisiranezetimibehypercholesterolaemiatertiary hospitalhypertriglyceridemia
… included (40% women; 60±7 years), all in secondary prevention. Inclisiran was indicated for failure to reach LDL-C targets despite optima…
ezetimiberosuvastatinhigh-intensity statinmoderate-intensity statinacute myocardial infarctionAMINCT04499859Institutional Review Board of Seoul St. Mary’s HospitalHigh-intensity statin therapy
…randomised 1:1 to receive either moderate-intensity statin with ezetimibe (rosuvastatin 5 mg with ezetimibe 10 mg) or high-intensity stat…
EzetimibeAtorvastatinPCSK9 inhibitorsAcute Coronary SyndromeDiabetes MellitusSandwell and West Birmingham NHS TrustACS
…80 mg or equivalent on admission 88.15%(n=67)93.8% (n=61)p=0.22 Ezetimibe 10 mg on admission 65.7%(n=50)73.8% (n=48)p=0.56 PCSK9 inhibito…
Inclisiranezetimibehyperlipidaemiadiabeteschronic kidney diseasehypertension
…ients reporting mild local injection site irritation.Conclusion Inclisiran significantly reduces LDL cholesterol levels, with the greatest…
ezetimibehigh-intensity statinshigh-intensity statinHigh intensity statinACSacute coronary syndrome (ACS)STEMI
…ts, only 3 (8.3%) had therapy intensified limited to the use of ezetimibe, highlighting a critical gap in care.Abstract 7-010 Table 1 Var…
ezetimibeinclisiranChronic kidney diseaseCKDdiabetes
…HMG CoA) reductase inhibitors (statins), alone or combined with ezetimibe, are the most extensively studied treatment in reducing cholest…
Bempedoic acidBAezetimibeEZE-FDC
…. cData missing for 14 patients.BA, bempedoic acid; BA+EZE-FDC. Bempedoic acid/ezetimibe fixed-dose combination; HeFH, heterozygous familial h…